Medical device and MedTech insights, news, tips and more

FDA Clearance Awarded to Tyber Medical for NiTy+ One-Shot Staple Fixation System

November 15, 2022

(PRNewsfoto/Tyber Medical, LLC)

Tyber Medical LLC, the global, leading private-label medical device provider for major orthopedic trauma, extremity, and spine companies, has been awarded a U.S. Food and Drug Administration (FDA) 510(k) clearance for its new NiTy+ One-Shot™ Staple Fixation System. The NiTy+ One-Shot is the first instrument of its kind in the bone-fixation device market to feature a uniquely designed, single-pass insertion instrument. Designed with surgical efficiency in mind, the NiTy+ One-Shot is particularly beneficial in the case of fracture, osteotomy fixation, and joint arthrodesis.

“We are pleased to receive another FDA clearance that extends our reach into the orthopedic device market with our ever-growing suite of cleared bone-fixation devices,” said Tyber Medical CEO and President Jeff Tyber. “Our product design and engineering team developed a superior method for staple implantation that enhances surgical efficiency. With one instrument, surgeons can deploy and insert staples, while remaining focused on the field of view at all times.”

The system’s innovative insertion tool is equipped with pre-loaded staples and an integrated tamping mechanism, eliminating the need for a second instrument to fully seat staples into the bone requiring fixation. Two instruments are combined into a single insertion tool, which can also reattach to the staple, allowing enhanced positioning control.

According to Tyber Medical’s Senior Project Engineer Abe Perryman, physicians have responded favorably to the company’s new staple system. “The feedback we have received from surgeons involved in the cadaveric trials has been overwhelmingly positive. What they appreciate most is how our innovative insertion tool allows for streamlined bone staple implantation in orthopedic extremities surgery,” Perryman said.

Tyber Medical’s NiTy+ One-Shot Staple Fixation System consists of sterile, single-use orthopedic implants and fully disposable instruments, removing the need for facility reprocessing. The compression staples are constructed from super-elastic nickel-titanium (Nitinol) and are available in two or four-legged designs with multiple combinations of bridge widths, leg lengths, and cross sections to accommodate various anatomies and pathologies. The staple implant applies optimum compression across bone segments when the staple implant legs are released. The disposable inserter supplies opposing forces to the staple legs to keep them parallel during implantation.

About Tyber Medical LLC

Tyber Medical is committed to providing rapid access to FDA-cleared and CE-marked private label, orthopedic device technology that advance patient care and healing outcomes. Since its founding in 2012, Tyber Medical LLC has released more than fifty extremity/trauma/spine systems, quickly becoming a leading orthopedic device provider. The company’s medical device portfolio effectively offers its partners a quick and seamless path to market, by filling product offering gaps in as little as four months through vertically integrated design, engineering, manufacturing, quality management, regulatory, clinical research, and MDR compliance. Tyber Medical is committed to developing and utilizing differentiated, bioengineered technologies, including unique surface treatments and coatings, to make advanced orthopedic implants.

See Full Press Release at the Source: FDA Clearance Awarded to Tyber Medical for NiTy+ One-Shot Staple Fixation System

Press Release by: Tyber Medical

Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.